GovChime
Notice ID: e9d7349accaff984dc85b5454e5c9cfaPresolicitation

A--CRYOGENIC FLUID MANAGEMENT SUPPORT

Archived on May 4, 2009. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 AM UTC−05:00
Posted
April 16, 2009
Notice type
Presolicitation
NAICS
541712: Classification Not Available

Notice details

PSC
A: RESEARCH AND DEVELOPMENT
Last updated
Sep 25, 2026

Identifiers

Solicitation number
NNM09288001R
Notice ID
e9d7349accaff984dc85b5454e5c9cfa

Description

NASA/MSFC has a requirement for a follow-on contract to provide Cryogenic FluidManagement (CFM) in support of Altair, Ares V, Lunar Surface Systems, and GroundOperations Constellation programs.NASAs CFM Project effort provides NASA MSFC with continued development and validation ofnovel system concepts and high-leverage technologies to enable safe, affordable andsustainable human and robotic exploration. Critical to this effort is the ability tostore and manage cryogenic propellants in space for the development of explorationstrategies and commercial space activities consistent with Constellation and theExploration Technology Development Program (ETDP) objectives. NASA/MSFC intends to purchase the services from Alpha Technologies, Inc. pursuant to FAR6.302-1, which implements the authority for 10 U.S.C. 2304(c)(1) for acquisition ofsupplies or services from only one source and no other supplies or services will satisfyagency requirements. Competition is impractical for the following reasons:A follow-on contract is needed to maintain continuity in CFM expertise support that AlphaTechnology, Inc. is currently providing under contract with MSFCs Propulsion SystemsDepartment. Alpha Technology, Inc.s resident CFM expert brings 48 years of experienceas a leading CFM Technologist and is intimately engaged in ongoing CFM work, includingexperiments, tests, planning and documentation. The CFM Project has an aggressive schedule of milestones and product deliverables ofwhich Alpha Technology, Inc. is at this time heavily involved. Continued AlphaTechnology, Inc. support for in-progress and ongoing CFM activities, is essential forsuccess from a fidelity and schedule standpoint.The Government does not intend to acquire a commercial item using FAR Part 12. See Note26.Interested organizations may submit their capabilities and qualifications to perform theeffort in writing to the identified point of contact not later than 4:30 p.m. local timeon 4/30/2009. Such capabilities/qualifications will be evaluated solely for the purposeof determining whether or not to conduct this procurement on a competitive basis. Adetermination by the Government not to compete this proposed effort on a full and opencompetition basis, based upon responses to this notice, is solely within the discretionof the government.Oral communications are not acceptable in response to this notice.All responsible sources may submit an offer which shall be considered by the agency.An Ombudsman has been appointed. See NASA Specific Note "B".Any referenced notes may be viewed at the following URLs linked below.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Emmett V Hernandez, Contract Specialist, Phone 256-544-9605, Fax 256-544-5028, Email Emeterio.V.Hernandez@nasa.gov - Lizette M Kummer, Contracting Officer, Phone 256-544-3457, Fax 256-544-5028, Email Lizette.M.Kummer@nasa.gov Emmett V Hernandez

Documents

No documents available.

Lifecycle

Solicitation:NNM09288001R
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentApr 16, 2009

    A--CRYOGENIC FLUID MANAGEMENT SUPPORT

    Notice e9d7349accaff984dc85b5454e5c9cfa on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
-Special NoticeOpen
No Description Provided
-Sole Source / J&AOpen
This is a posting of the redacted Justification and Authorization. Contract # W81XWH-16-P-0037 was awarded on 12/15/2015.
-Sole Source / J&AOpen
SOURCE SOUGHT NOTICE: DLA Aviation Philadelphia is seeking eligible contractors to furnish effort including labor, material, and facilities as may be required to manufacture the items as specified within this document. The Government intends to solicit and negotiate with only one source or a limited number of responsible sources under the authority of FAR 6.302-1. The Government intends to solicit for the procurement of: NSN 01-388-7478, P/N 626145-2, and the aircraft the item is used on or supports. The Government does not possess the data necessary to perform the required manufacture of the item. All responsible sources may express their interest and provide capability statements in response to this notice. This notice of intent is not a request for competitive proposals. However, all proposals received within 15 days after the date of publication of this Sources Sought Notice may be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Only approved sources will be solicited, and source approval may be required. DLA Aviation Philadelphia will not delay award while source approval is pending. The time required for approval of a new source is normally such that an award cannot be delayed pending approval of a new source. If you are not an approved source you must submit, together with your proposal, the information detailed in Source Approval Information Brochure for Spares. Additional information for submitting a Source Approval Request package can be obtained at: https://www.navsup.navy.mil/navsup/ourteam/navsupwss/business_opps/SAR%20Spares%20Brochure.pdf The POC is Marie Lisowski. Marie.Lisowski@dla.mil
-Market ResearchOpen
The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by reintroducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
-Pre-SolicitationOpen

Additional Details

Solicitation Number

NNM09288001R

Archive Date

May 4, 2009